Dr Liora Eidelstein, DDS, MS | |
78595 Ca-111, La Quinta, CA 92253 | |
(760) 771-0300 | |
Not Available |
Full Name | Dr Liora Eidelstein |
---|---|
Gender | Female |
Speciality | Dentist - Orthodontics And Dentofacial Orthopedics |
Location | 78595 Ca-111, La Quinta, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1225391865 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1223X0400X | Dentist - Orthodontics And Dentofacial Orthopedics | 58589 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Liora Eidelstein, DDS, MS 1626 Hampton Rd, Havertown, PA 19083-2506 Ph: () - | Dr Liora Eidelstein, DDS, MS 78595 Ca-111, La Quinta, CA 92253 Ph: (760) 771-0300 |
News Archive
Medicare patients accounted for almost half of all stays (45 percent) at rural hospitals in 2007, while the percentage of Medicare beneficiaries who were admitted to urban hospitals was considerably lower (35 percent) , according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
The results of the project, developed by researchers of the Center for Applied Medical Research (CIMA) of the University of Navarra have been published in the journal Neuropsychopharmacology.
Initial findings show most women recorded some problems in the days leading up to their period, with 21 per cent of the sample studied suffering with two or more symptoms. In addition, the chances of having symptoms are more likely for heavier women with a higher BMI and less likely for women using hormonal contraception such as the Pill or the contraceptive injection.
A.P. Pharma, Inc., a specialty pharmaceutical company, today announced that, on November 19, 2009, the Company received notice from the Nasdaq Listing Qualifications Panel that it has regained compliance with the shareholders' equity requirement for continued listing on the Nasdaq Capital Market.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in the U.S. and Europe, a drug that resolves tophi in less than one year would become the patient share leader in the chronic tophaceous gout patient subpopulation and would be used in the vast majority of patients who suffer severe tophaceous gout, according to surveyed U.S. and European rheumatologists.
› Verified 3 days ago
Dr. Heather Hana Park, DDS Dentist Medicare: Medicare Enrolled Practice Location: 78595 Highway 111 Ste 300, La Quinta, CA 92253 Phone: 760-771-0300 | |
Dr. Morris Davidowitz, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 61567 Toro Canyon Way, La Quinta, CA 92253 Phone: 650-580-4153 | |
Dr. Bruce Uy, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 79080 Shadow Trl, La Quinta, CA 92253 Phone: 760-619-4954 | |
Jaime Rojas, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 78640 Highway 111, La Quinta, CA 92253 Phone: 760-564-0955 Fax: 760-564-4826 | |
Dr. David Michael Long, DDS, MS Dentist Medicare: Medicare Enrolled Practice Location: 78461 Highway 111, La Quinta, CA 92253 Phone: 760-861-9599 | |
Dr. Richard W Zawadzki, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 78595 Highway 111, Ste. 300, La Quinta, CA 92253 Phone: 760-771-0300 Fax: 760-771-0420 |